About: Stefano A Pileri

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Stefano A Pileri Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
field of work	wds:Q86426885-925B44D7-A8E1-4303-ADB2-CEE5FBCC4CC9 wds:Q86426885-C30A9E93-B243-43CC-8248-F12D532DB2D6 wds:Q86426885-FAEF8248-69CC-44D6-A5C9-CFA30467D1DC
field of work	anatomical pathology hematology pathology
description	researcher (en) investigador (es) wetenschapper (nl) дослідник (uk) italský patolog a vysokoškolský pedagog, zaměřený na hematopatologii a patologockou anatomii (cs)
rdfs:label	Stefano A Pileri (en) Stefano A Pileri (nl) Stefano A. Pileri (cs) Stefano A. Pileri (sk)
skos:prefLabel	Stefano A Pileri (en) Stefano A Pileri (nl) Stefano A. Pileri (cs) Stefano A. Pileri (sk)
name	Stefano A Pileri (en) Stefano A Pileri (nl) Stefano A. Pileri (cs) Stefano A. Pileri (sk)
given name	wds:Q86426885-265AB9EE-E8F2-4A9F-8871-E37E5F66111A
given name	Stefano
instance of	wds:Q86426885-3DA93DCE-35F7-4E0C-B16F-D8A5BE633B20
NL CR AUT ID	wds:Q86426885-B0458722-64A8-4E7A-8E1C-EBC0FCCE4F35
instance of	Homo sapiens
NL CR AUT ID	xx0218407
skos:altLabel	Stefano A. Pileri (en) Stefano Pileri (en)
occupation	wds:Q86426885-04A5CE53-5163-48A6-AE53-F3838FF5E29D wds:Q86426885-40B65ED7-2779-4C01-9061-5F4C47EE3E97
employer	wds:Q86426885-2E27B28E-9CF3-4D5A-875F-5D5D54302EE2
languages spoken, written or signed	wds:Q86426885-0D03A6CB-F040-4438-958C-D6F8106B7DEE wds:Q86426885-889D05D0-7C14-41F9-8268-27404999F50E
sex or gender	wds:Q86426885-A23B62B1-330C-4A98-A864-02A71446303E
VIAF ID	wds:Q86426885-006D8D47-28E4-459A-87BF-98D15A21C8AF
IdRef ID	wds:Q86426885-e32a8089-052c-4e0c-b28c-ed4ad497350b
date of birth	wds:Q86426885-B99AB310-9FF9-4F61-B0ED-BC43EBF2140A
family name	wds:Q86426885-E0DFE6F5-DF2B-48FF-9A78-5090F82049D1
VIAF ID	http://viaf.org/viaf/115151302931848661038
IdRef ID	http://www.idref.fr/219965811/id
occupation	university teacher pathologist
employer	European Institute of Oncology
languages spoken, written or signed	English Italian
sex or gender	male
VIAF ID	115151302931848661038
IdRef ID	219965811
date of birth	1947-01-01 00:00:00Z (xsd:dateTime)
family name	Pileri
ORCID iD	wds:Q86426885-F3453DB3-0286-4CAA-BCDF-8C19820F7FC3
ORCID iD	https://orcid.org/0000-0001-8032-5128
ORCID iD	0000-0001-8032-5128
is owl:sameAs of	Stefano A Pileri
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q86426885
is author of	Tumor protein D52 (TPD52): a novel B-cell/plasma-cell molecule with unique expression pattern and Ca(2+)-dependent association with annexin VI The expression pattern of c-mpl in megakaryocytes correlates with thrombotic risk in essential thrombocythemia Induction of p53 and up-regulation of the p53 pathway in the human 5q- syndrome Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation whereas its deficiency favors myeloid cell expansion. Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1) Immunoglobulin gene rearrangement analysis in composite hodgkin disease and large B-cell lymphoma: evidence for receptor revision of immunoglobulin heavy chain variable region genes in Hodgkin-Reed-Sternberg cells? Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins Pathobiology of primary mediastinal B-cell lymphoma Antigen retrieval techniques in immunohistochemistry: comparison of different methods Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells. EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project BRAF mutations in hairy-cell leukemia Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine. Nodal marginal-zone lymphoma associated with monoclonal light-chain and heavy-chain deposition disease. IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas Histopathological and molecular features of persistent polyclonal B-cell lymphocytosis (PPBL) with progressive splenomegaly. Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas. Yttrium-90 ibritumomab tiuxetan as a single agent in patients with pretreated B-cell lymphoma: evaluation of the long-term outcome New molecular insights into peripheral T cell lymphomas Expression of CD52 in peripheral T-cell lymphoma Peripheral T cell lymphomas with follicular T helper phenotype: a new basket or a distinct entity? Revising Karl Lennert's personal archive Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets Peripheral T-cell lymphoma classification: the matter of cellular derivation. Targeted molecular therapy in peripheral T-cell lymphomas BCL10 down-regulation in peripheral T-cell lymphomas. Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial. Revising the historical collection of epithelioid cell-rich lymphomas of the Kiel Lymph Node Registry: what is Lennert's lymphoma nowadays? High resolution SNP array genomic profiling of peripheral T cell lymphomas, not otherwise specified, identifies a subgroup with chromosomal aberrations affecting the REL locus. Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation Expression of platelet-derived growth factor receptor alpha in peripheral T-cell lymphoma not otherwise specified Anaplastic large cell lymphoma, ALK-positive Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software